1360 related articles for article (PubMed ID: 15955463)
1. Effect of antiatherogenic L-aspartate and L-glutamate on serum lipoproteins cholesterol and apolipoproteins A-1 and B in rabbits fed with high cholesterol diet.
Yanni AE; Perrea DN; Yatzidis HA
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):161-5. PubMed ID: 15955463
[TBL] [Abstract][Full Text] [Related]
2. Appreciation of concentration of lipoproteins and apolipoproteins in serum of male rats under the influence of diet change composition and its supplementation with group B vitamins.
Goluch-Koniuszy Z; Wierzbicka A
Acta Sci Pol Technol Aliment; 2011; 10(1):113-21. PubMed ID: 22232533
[TBL] [Abstract][Full Text] [Related]
3. ApoB but not LDL-cholesterol is reduced by exercise training in overweight healthy men. Results from the 1-year randomized Oslo Diet and Exercise Study.
Holme I; Høstmark AT; Anderssen SA
J Intern Med; 2007 Aug; 262(2):235-43. PubMed ID: 17645591
[TBL] [Abstract][Full Text] [Related]
4. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women.
Matthan NR; Welty FK; Barrett PH; Harausz C; Dolnikowski GG; Parks JS; Eckel RH; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1092-7. PubMed ID: 15087307
[TBL] [Abstract][Full Text] [Related]
5. Dietary L-aspartate and L-glutamate inhibit fatty streak initiation in cholesterol-fed rabbit.
Yanni AE; Yatzidis HA; Kavantzas NG; Agapitos EV; Perrea DN; Karayannacos PE
Nutr Metab Cardiovasc Dis; 2003 Apr; 13(2):80-6. PubMed ID: 12929620
[TBL] [Abstract][Full Text] [Related]
6. Oral supplementation with L-aspartate and L-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbit.
Yanni AE; Agrogiannis G; Nomikos T; Fragopoulou E; Pantopoulou A; Antonopoulou S; Perrea D
Amino Acids; 2010 May; 38(5):1323-31. PubMed ID: 19701712
[TBL] [Abstract][Full Text] [Related]
7. Serum trypsin-like activity in chronic alcoholized men: possible relationship with lipids, apoA-1 and apoB lipoproteins.
Joly JP; Sesboüe R; Hillemand B; Martin JP
Alcohol Alcohol; 1992 Sep; 27(5):563-9. PubMed ID: 1476559
[TBL] [Abstract][Full Text] [Related]
8. TRL, IDL, and LDL apolipoprotein B-100 and HDL apolipoprotein A-I kinetics as a function of age and menopausal status.
Matthan NR; Jalbert SM; Lamon-Fava S; Dolnikowski GG; Welty FK; Barrett HR; Schaefer EJ; Lichtenstein AH
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1691-6. PubMed ID: 15933247
[TBL] [Abstract][Full Text] [Related]
9. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
[TBL] [Abstract][Full Text] [Related]
10. Errors that result from using the TC/HDL C ratio rather than the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease.
Sniderman AD; Jungner I; Holme I; Aastveit A; Walldius G
J Intern Med; 2006 May; 259(5):455-61. PubMed ID: 16629851
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between gene polymorphism at the apolipoprotein E locus and serum lipid profile in urban children of school age in Beijing].
Zhu W; Feng N; Wang Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Sep; 35(5):297-300. PubMed ID: 11769625
[TBL] [Abstract][Full Text] [Related]
12. Anti-atherogenic effects of seabuckthorn (Hippophaea rhamnoides) seed oil.
Basu M; Prasad R; Jayamurthy P; Pal K; Arumughan C; Sawhney RC
Phytomedicine; 2007 Nov; 14(11):770-7. PubMed ID: 17498939
[TBL] [Abstract][Full Text] [Related]
13. Lipid and lipoprotein profiles relate to peak aerobic power in spinal cord injured men.
Bostom AG; Toner MM; McArdle WD; Montelione T; Brown CD; Stein RA
Med Sci Sports Exerc; 1991 Apr; 23(4):409-14. PubMed ID: 2056897
[TBL] [Abstract][Full Text] [Related]
14. The association of serum lipids, lipoproteins and apolipoproteins with selected trace elements and minerals in phenylketonuric patients on diet.
Schulpis KH; Karakonstantakis T; Bartzeliotou A; Karikas GA; Papassotiriou I
Clin Nutr; 2004 Jun; 23(3):401-7. PubMed ID: 15158304
[TBL] [Abstract][Full Text] [Related]
15. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
[TBL] [Abstract][Full Text] [Related]
16. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
[TBL] [Abstract][Full Text] [Related]
17. Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.
Kappelle PJ; Gansevoort RT; Hillege HJ; Wolffenbuttel BH; Dullaart RP;
J Clin Lipidol; 2013; 7(1):56-64. PubMed ID: 23351584
[TBL] [Abstract][Full Text] [Related]
18. Effects of glibenclamide on serum lipids, lipoproteins, thromboxane, beta-thromboglobulin, and prostacyclin in non-insulin-dependent diabetes mellitus.
Waysbort J; Regitz G; Chaimowitz D; Tuval M; Nakash I; Brunner D
Clin Ther; 1988; 10(4):358-71. PubMed ID: 2978874
[TBL] [Abstract][Full Text] [Related]
19. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
20. MaxEPA fish oil enhances cholesterol-induced intimal foam cell formation in rabbits.
Rogers KA; Adelstein R
Am J Pathol; 1990 Oct; 137(4):945-51. PubMed ID: 2221018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
